Schuchardt C, Zhang J, Kulkarni HR, Chen X, et al. Prostate-specific membrane antigen radioligand therapy using (177)Lu-PSMA I&T and (177)Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: comparison of safety, biodistribution and dosimetry. J Nucl Med 2021 Dec 9. pii: jnumed.121.262713. doi: 10.2967/jnumed.121.262713.
PMID: 34887335